1991 OUTSTANDING YEAR FOR AMERICAN HOME
New sales and earnings records were achieved in 1991 by American Home Products (Mar-ketletter January 20). The year was said to have been an outstanding one, in which steps were taken to strengthen key areas, and towards the introduction of new products and the formation of major joint ventures, said company chairman John Stafford in the group's annual report for that year.
Mr Stafford said that the acquisition of a majority stake in the US biotechnology concern, Genetics Institute, (Marketletter September 30, 1991) represents a quantum leap for AHP towards its goal of becoming a premier company in the field of biotechnology.
Some of AHP's key initiatives in 1991 were described as follows: to bring important therapeutic advances to the medical community; discover and develop innovative therapies; respond to increased interest in self-medication; feature safety and advanced technology in medical supplies and instrumentation; provide leadership in animal health care; and focus on foods for healthier living.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze